| Originality | The abstract submitted must be of an original scientific nature and have not been previously published in whole or part by any journal or publication. |
| Language | Abstracts MUST be submitted in English. Mode of Presentation. The Programme Committee reserves the right to select and assign the abstracts relevant to the sessions for oral or poster presentation. |
| Acknowledgement of Receipt | Upon submission, authors will receive a confirmation by email. Otherwise, please contact the Congress Secretariat. Review and Selection. Abstracts will be double-blind and peer reviewed by an international panel of eminent experts. Selection will be based upon: relevance to theme, originality and interest, clinical and research content, and state of completeness. |
| Notifications | Notifications of Acceptance will be sent to presenting authors along with the details of the presentation format. |
| Registration | All presenting authors of abstracts (either oral or poster) are required to register and pay the registration fee by the deadline. Failure to do so will result in exclusion from the final programme. Publication. All accepted abstracts will be published in the Scientific Proceedings of the congress in electronic format upon receipt of registration fees in full. Authors will be required to sign copyright transfers to Organising committee. |
| Publication | All accepted abstracts will be published in the Scientific Proceedings of the congress in electronic format upon receipt of registration fees in full. Authors will be required to sign copyright transfers to Organising committee. |
Abstracts should be any of the following theams:
|
|
| Word Limit | Abstracts cannot exceed 500 words. A maximum of 2 graphs, tables or images saved in JPEG/GIF/ TIF format of at least 300 dpi can be included in your abstract. |
| Title | Abstract title must be in Title Case, e.g. Asian Pacific Congress of Nephrology. The title should be brief and descriptive. |
| Content | Each abstract must contain sufficient details for evaluation. Make the abstract as informative as possible. Clearly indicate the aims and conclusions supported by data. Results stated in the abstracts must be complete (though concise) and final. Organize the body of the abstract as follows: (a) objectives, (b) methods, (c) results, (d) conclusions. Use standard abbreviations and generic drug names. Place unusual abbreviations or acronyms in parentheses at first use. Do not identify author(s) or institution(s) in text. |
Your abstract will undergo a double-blind peer review by the Scientific committee within two to three weeks after the last date of submission.All abstracts will be reviewed using four criteria:
These reviews will be passed on to the Organising Committee, which will make a final decision on which abstracts to accept and in what categories.
Results of the abstract review will be sent to the author within two weeks of submission
The Conference Chair serves as the head of the scientific committee and will take the final decision on abstracts.
Acceptance or rejections of the paper will be sent to you with reviewer comments.
If a revision is required, the revised abstract must be sent back within a week If your abstract is accepted, only if you are registered.
Please note a single registration permits only one person to attend the conference
If the co-authors would like to attend the conference their registration and payment are required to be made independently as delegate
The certificate will be issued for the co-authors upon their registration/payment for the conference.
Please make prior communications with the organizing committee regards to this matter to enjoy the benefits.
The preferred mode of presentation can be selected during abstract submission. The final mode of presentation for the accepted abstracts will be determined by the Scientific Committee.
Oral Presentation |
Presenters will be allocated either 05 or 10 minutes to present and engage in discussion. |
Case Studies |
Presenters will be allocated either 05 or 10 minutes for presentation and discussion of the case study |
Symposium |
|
Poster Presentation |
There will be a dedicated area and timeslot for poster presentations and interactions with delegates |
Virtual presentation |
Only for virtual attendee |
